Cytokinetics, Incorporated (CYTK) Operating cash flow 2016–2025
Cytokinetics, Incorporated (CYTK) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$510.0MFY2025 · since FY2016: $37.0M → -$510.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$510.0M | -28.8% |
| FY2024 | -$395.9M | +4.5% |
| FY2023 | -$414.3M | -38.3% |
| FY2022 | -$299.5M | -110.2% |
| FY2021 | -$142.5M | -1693.7% |
| FY2020 | $8.9M | +109.8% |
| FY2019 | -$90.9M | +10.2% |
| FY2018 | -$101.2M | +0.5% |
| FY2017 | -$101.8M | -375.2% |
| FY2016 | $37.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice